Torrent Pharma In A Medium-Term Uptrend

The stock breached 50-and 200-day moving averages; key resistance now at ₹1,850

- Yoganand D

Here are answers to readers’ queries on the performance of their stock holdings.

What is the short-term outlook of Torrent Pharmaceuticals? I would like to buy for a short term horizon.

Ashish

Torrent Pharmaceuticals (₹1,814.9): The stock of Torrent Pharmaceuticals in on an uptrend across all time-frames — short-, medium- and long-term. It took support at around ₹1,500 in July year and resumed the long-term uptrend.

Since July, the stock has been in a medium-term uptrend. After a minor correction in September, the stock took support at ₹1,600 in early October and continued to trend upwards; it has been on a short-term uptrend since then.